Arvinas, Inc. Gains 95.06%

Arvinas, Inc. (ARVN:NASDAQ) soared at $58.38, representing a gain of 95.1%. On Fri 11 Dec 20, ARVN:NASDAQ hit a New 2-Week High of $29.93. The stock got featured on our News Catalysts scanner on Mon 14 Dec 20 at 04:54 PM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 70.00% Up Days and 72.73% Green Days

The share price of the company has been moving sideways in recent weeks.

About Arvinas, Inc. (ARVN:NASDAQ)

Arvinas Inc, formerly Arvinas Holding Co LLC is a private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary PROTAC protein degraders, or Proteolysis-Targeting Chimera, work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins.